The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of neoadjuvant chemoradiation (CRT) with midostaurin, 5-fluorouracil (5-FU) and radiation (XRT) for locally advanced rectal cancer: Sensitization of RAS mutant tumors.
 
Theodore S. Hong
Consulting or Advisory Role - Clinical Genomics
Research Funding - Novartis (Inst); Taiho Pharmaceutical
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
David P. Ryan
Stock and Other Ownership Interests - MPM Capital
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - MPM Capital
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
 
Hui Zheng
No Relationships to Disclose
 
Darrell R Borger
No Relationships to Disclose
 
Eunice Lee Kwak
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen
 
Jill N. Allen
No Relationships to Disclose
 
David L. Berger
No Relationships to Disclose
 
David W Rattner
No Relationships to Disclose
 
James C. Cusack
Honoraria - Parexel
Consulting or Advisory Role - Verthermia
Research Funding - Karyopharm Therapeutics
 
Angelo J Gemma
No Relationships to Disclose
 
Harvey J. Mamon
No Relationships to Disclose
 
Christine E Eyler
No Relationships to Disclose
 
Paul C. Shellito
No Relationships to Disclose
 
Andrew X. Zhu
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Exelixis; Lilly; Merck; Novartis; Sanofi
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
 
Lipika Goyal
No Relationships to Disclose
 
Jeffrey W. Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Henning Willers
No Relationships to Disclose
 
Kevin M. Haigis
No Relationships to Disclose